Document Detail

Cyclosporine A alleviates severe anaemia associated with refractory large granular lymphocytic leukaemia and chronic natural killer cell lymphocytosis.
MedLine Citation:
PMID:  8639439     Owner:  NLM     Status:  MEDLINE    
Large granular lymphocytic (LGL) leukaemia and chronic natural killer cell lymphocytosis (CNKL) are chronic indolent disorders often associated with neutropenia and constitutional symptoms. Severe anaemia occurs in about 20% of patients and is currently treated with corticosteroids followed by oral cyclophosphamide in non-responders. 30% of patients fail initial measures, and salvage therapy is inadequate. We describe three transfusion-dependent patients (two with T-LGL leukaemia, one with CNKL) refractory to corticosteroids, cyclophosphamide, and in one case fludarabine. Cyclosporine A (CSA) initiation resulted in prompt transfusion-independence and was well tolerated in all patients, making it an attractive alternative therapy for this disorder.
K C Bible; A Tefferi
Related Documents :
21555939 - Admission with metabolic disorder is a useful predictor of the 1-year prognosis for pat...
18503589 - Eculizumab, a terminal complement inhibitor, improves anaemia in patients with paroxysm...
6581839 - Studies on pure red cell aplasia. xi. results of immunosuppressive treatment of 37 pati...
9933139 - Limited erythropoietic response to combined treatment with recombinant human interleuki...
12095599 - The role of laparoscopic cholecystectomy in the management of acute cholecystitis in pa...
16997049 - The epidemiology of hemoglobin levels in patients with type 2 diabetes.
20962699 - Contralateral suppression of otoacoustic emissions in tinnitus patients.
22749919 - The incidence rate of post-stroke epilepsy: a 5-year follow-up study in taiwan.
7182949 - Time-domain remarks on the cycle-to-cycle variability in some quantities measured on th...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  British journal of haematology     Volume:  93     ISSN:  0007-1048     ISO Abbreviation:  Br. J. Haematol.     Publication Date:  1996 May 
Date Detail:
Created Date:  1996-07-15     Completed Date:  1996-07-15     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0372544     Medline TA:  Br J Haematol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  406-8     Citation Subset:  IM    
Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anemia / drug therapy*,  etiology
Chronic Disease
Cyclosporine / therapeutic use*
Dose-Response Relationship, Drug
Killer Cells, Natural / pathology
Leukemia, T-Cell / complications*
Lymphocytosis / complications,  drug therapy*
Middle Aged
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  BCR rearrangement without juxtaposition of ABL in pre-T acute lymphoblastic leukaemia.
Next Document:  2-Chlorodeoxyadenosine in the treatment of hairy cell leukaemia: differences in response in patients...